Status:

WITHDRAWN

The Impact of Continuous Glucose Monitoring Use on Sleep in Parents of Children With Type 1 Diabetes Mellitus

Lead Sponsor:

Wolfson Medical Center

Collaborating Sponsors:

Tel Aviv Medical Center

Sheba Medical Center

Conditions:

Type 1 Diabetes

Eligibility:

All Genders

20-70 years

Brief Summary

The purpose of this prospective exploratory study is to compare sleep quality and sleep-wake patterns in parents of children with type 1 diabetes (T1D) before and several weeks after initiating using ...

Detailed Description

Few weeks before scheduled initiation of RT-CGM use of a child with T1D, the 'dominant parent' (the main caregiver during the nighttime in the family) will obtain an informed consent. This will be don...

Eligibility Criteria

Inclusion

  • Parents of children up to 16 years old with type 1 diabetes

Exclusion

  • Either the child or parent had obstructive sleep apnea, narcolepsy, or restless legs syndrome.

Key Trial Info

Start Date :

August 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01425255

Start Date

August 1 2011

End Date

August 1 2012

Last Update

June 21 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

E. Wolfson Medical Center

Holon, Israel, 58100

The Impact of Continuous Glucose Monitoring Use on Sleep in Parents of Children With Type 1 Diabetes Mellitus | DecenTrialz